A Dose of a Hallucinogen From a ‘Magic Mushroom,’ and Then Lasting Peace

A report on the dramatic results of the Johns Hopkins and NYU psilocybin cancer studies. In both trials, some 80 percent of cancer patients showed clinically significant reductions in standard measures of anxiety and depression, an effect that endured for at least six months after their psilocybin session.

Read More